{"record":{"code":"W-01606","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"PFE · SUB · EC · CENTRO DE ESPECIALIDADES CENTRAL GUAYAS","buyer":"","amount":76174.56,"currency":null,"records":2,"found":"2026-10-04","refs":["SICM-197-2016-C","ocds-5wno2w-CE-20210001960081-2739","ocds-5wno2w-CE-20240002561035-2739","2012-08-07"],"id":"W-01606","html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01606/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01606/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «PFIZER PFE CIA.LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 2 non-competitive contracts at the buyer «CENTRO DE ESPECIALIDADES CENTRAL GUAYAS», 76,175 USD (≈ $76,175); method direct (Catálogo electrónico - Compra directa en el convenio SICM-197-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001960081-2739, ocds-5wno2w-CE-20240002561035-2739; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase).","facts":[["Company / subject","PFE · SUB · EC · CENTRO DE ESPECIALIDADES CENTRAL GUAYAS",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","76,175",null],["Records behind the indicator","2",null],["Found","4 October 2026",null],["Code","W-01606",null],["Reference","SICM-197-2016-C",null],["Reference","ocds-5wno2w-CE-20210001960081-2739",null],["Reference","ocds-5wno2w-CE-20240002561035-2739",null],["Reference","2012-08-07",null]],"summary":"subsidiary/issuer «PFIZER PFE CIA.LTDA.» ↔ SEC PFE (CIK 78003, PFIZER INC): 2 non-competitive contracts at the buyer «CENTRO DE ESPECIALIDADES CENTRAL GUAYAS», 76,175 USD (≈ $76,175); method direct (Catálogo electrónico - Compra directa en el convenio SICM-197-2016-C, ADQUISICION DE CATALOGO DE MEDICAMENTOS, SELECCIÓN DE PROVEEDORES PARA LA PROVISIÓN DE MEDICAMENTOSDE USO Y CONSUMO; OCID ocds-5wno2w-CE-20210001960081-2739, ocds-5wno2w-CE-20240002561035-2739; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); ↓ weak method (catalogue / exclusivity / accreditation / small purchase)","entity":"e56e0cee"},"about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","evidence":[],"row":{"country":"Ecuador","iso2":"EC","part":"Findings","indicator":"Debarred / sanctioned abroad × US SEC issuer","about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","findings":84,"new_today":0,"on_pages":84,"full_list":[],"html":"https://worldwide-corruption.com/database/ecuador/findings/fcpa-pattern/","json":"https://worldwide-corruption.com/database/ecuador/findings/fcpa-pattern/index.json"},"other_records_of_this_company":[],"html":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01606/","json":"https://worldwide-corruption.com/record/ecuador/findings/fcpa-pattern/W-01606/index.json"}